How to Inject Retatrutide GLP-1 medications, such as Wegovy (semaglutide) and Mounjaro (tirzepatide) are groundbreaking treatment options for weight management and type 2 diabetes management
Food and Drug Administration approved its daily oral orforglipron pill, which will be marketed under the name Foundayo, to treat obesity
Her advice before you go any further
These molecules are designed to activate beneficial signaling pathways while minimizing beta-arrestin recruitment that drives desensitization
Some people taking GLP-1 medications may experience digestive side effects, with these being the most common: Nausea, especially at the start or after a dose increase Heartburn or stomach discomfort after meals Constipation, which can occur as the body adjusts Diarrhea, which may be mild or bothersome Vomiting, sometimes along with nausea Most digestive side effects lessen as the body adjusts
Tirzepatide's mechanism stays within incretin pathways, which is why its weight-loss ceiling sits below retatrutide's in head-to-head modelling